For Wegovy, 90% of patients with coverage pay $0 to $25 per month, according to Pharmacy Times in 2025, so verifying coverage is essential
In one study conducted in Germany, overweight participants received a regular diet, either with or without the addition of L-carnitine
Key information to disclose includes: Medication name and dose "I take Wegovy (semaglutide) 2.4 mg once weekly by subcutaneous injection" Duration of treatment how long you have been taking Wegovy and whether you are still in the dose-escalation phase Current side effects any ongoing nausea, vomiting, diarrhoea, dizziness, or other symptoms Reason for prescription whether prescribed for obesity alone or with comorbidities such as type 2 diabetes, hypertension, or cardiovascular disease Overall health status current weight, blood pressure, and general wellbeing Donation staff will ask about your medical history and may need to consult with medical advisors regarding Wegovy
Andrea Johnsons Clinic for Semaglutide Treatment
Also explore our Recovery Research range